129 related articles for article (PubMed ID: 24732701)
1. A paradoxical pattern of indoleamine 2,3-dioxygenase expression in the colon tissues of patients with acute graft-versus-host disease.
Park G; Choi YJ; Lee SE; Lim JY; Lee C; Choi EY; Min CK
Exp Hematol; 2014 Sep; 42(9):734-40. PubMed ID: 24732701
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Xu J; Wei J; Zhu X; Zhang X; Guan J; Wang J; Yin J; Xiao Y; Zhang Y
Biol Blood Marrow Transplant; 2013 Feb; 19(2):196-201. PubMed ID: 23089565
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: association with the induction of allogeneic immune tolerance?
Steckel NK; Kuhn U; Beelen DW; Elmaagacli AH
Scand J Immunol; 2003 Feb; 57(2):185-91. PubMed ID: 12588666
[TBL] [Abstract][Full Text] [Related]
4. miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
Zhao XS; Wang YN; Lv M; Kong Y; Luo HX; Ye XY; Wu Q; Zhao TF; Hu YH; Zhang HY; Huo MR; Wan J; Huang XJ
Oncotarget; 2016 Jul; 7(30):48321-48334. PubMed ID: 27340781
[TBL] [Abstract][Full Text] [Related]
5. Potential immunosuppressive function of plasma indoleamine 2,3-dioxygenase in patients with aGVHD after allo-HSCT.
Zhao XS; Liu KY; Liu DH; Xu LP; Chen H; Huang XJ
Clin Transplant; 2011; 25(3):E304-11. PubMed ID: 21355883
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality.
Jasperson LK; Bucher C; Panoskaltsis-Mortari A; Taylor PA; Mellor AL; Munn DH; Blazar BR
Blood; 2008 Mar; 111(6):3257-65. PubMed ID: 18077788
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase.
Landfried K; Zhu W; Waldhier MC; Schulz U; Ammer J; Holler B; Wolff D; Edinger M; Peter K; Kreutz M; Andreesen R; Oefner PJ; Holler E
Blood; 2011 Dec; 118(26):6971-4. PubMed ID: 22039265
[TBL] [Abstract][Full Text] [Related]
8. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.
Jasperson LK; Bucher C; Panoskaltsis-Mortari A; Mellor AL; Munn DH; Blazar BR
Blood; 2009 Dec; 114(24):5062-70. PubMed ID: 19828695
[TBL] [Abstract][Full Text] [Related]
9. IDO in human gut graft-versus-host disease.
Ratajczak P; Janin A; Peffault de Larour R; Koch L; Roche B; Munn D; Blazar BR; Socié G
Biol Blood Marrow Transplant; 2012 Jan; 18(1):150-5. PubMed ID: 21835147
[TBL] [Abstract][Full Text] [Related]
10. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
[TBL] [Abstract][Full Text] [Related]
11. Inflamed intestinal mucosa features a specific epithelial expression pattern of indoleamine 2,3-dioxygenase.
Ferdinande L; Demetter P; Perez-Novo C; Waeytens A; Taildeman J; Rottiers I; Rottiers P; De Vos M; Cuvelier CA
Int J Immunopathol Pharmacol; 2008; 21(2):289-95. PubMed ID: 18547472
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.
Joo YD; Lee SM; Lee SW; Lee WS; Lee SM; Park JK; Choi IW; Park SG; Choi I; Seo SK
Immunology; 2009 Sep; 128(1 Suppl):e632-40. PubMed ID: 19740324
[TBL] [Abstract][Full Text] [Related]
13. The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer.
Gao YF; Peng RQ; Li J; Ding Y; Zhang X; Wu XJ; Pan ZZ; Wan DS; Zeng YX; Zhang XS
J Transl Med; 2009 Aug; 7():71. PubMed ID: 19695096
[TBL] [Abstract][Full Text] [Related]
14. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
15. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD.
Elmaagacli AH; Ditschkowski M; Steckel NK; Gromke T; Ottinger H; Hillen U; Baba HA; Trenschel R; Beelen DW; Koldehoff M
Bone Marrow Transplant; 2014 Jun; 49(6):800-5. PubMed ID: 24686986
[TBL] [Abstract][Full Text] [Related]
17. Increased Expression of Indoleamine 2,3-Dioxygenase (IDO) in Vogt-Koyanagi-Harada (VKH) Disease May Lead to a Shift of T Cell Responses Toward a Treg Population.
Zhang L; Huang Y; Cui X; Tan X; Zhu Y; Zhou W; Wang C; Yuan G; Cao Q; Su G; Kijlstra A; Yang P
Inflammation; 2020 Oct; 43(5):1780-1788. PubMed ID: 32435912
[TBL] [Abstract][Full Text] [Related]
18. Vascular Alterations in a Murine Model of Acute Graft-Versus-Host Disease Are Associated with Decreased Serum Levels of Adiponectin and an Increased Activity and Vascular Expression of Indoleamine 2,3-Dioxygenase.
Schmid PM; Bouazzaoui A; Schmid K; Birner CM; Schach C; Maier LS; Holler E; Endemann DH
Cell Transplant; 2016 Nov; 25(11):2051-2062. PubMed ID: 27196361
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
20. IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease.
Ju JM; Nam G; Lee YK; Jung M; Chang H; Kim W; Shon WJ; Lim JY; Kim JY; Chang J; Min CK; Lee DS; Choi K; Shin DM; Choi EY
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
